B.Riley initiates SiriusPoint stock with Buy rating, cites turnaround story

B.Riley initiated coverage on SiriusPoint Ltd (SPNT) with a Buy rating and a $30 price target, citing the company's significant turnaround progress and an undervalued GAAP book value when accounting for MGA investments, leading to a 1.9x price-to-book valuation. Trading at $19, SPNT shares have gained 14% year-to-date, outperforming specialty P&C peers, as the market recognizes its efforts and a forecasted 12% return on equity. This positive outlook is reinforced by Oppenheimer's recent Outperform rating and $25 target, which also highlighted SPNT's strategic overhaul and discounted valuation.

Analysis

SiriusPoint Ltd. (SPNT) has received strongly positive coverage from two separate research firms, signaling growing confidence in its corporate turnaround. B.Riley initiated coverage with a Buy rating and a $30 price target, a significant premium to its current $19 trading price. This valuation is based on a 1.9x price-to-book multiple, which B.Riley contends is conservative as it argues SPNT's GAAP book value of $15.73 is understated by approximately $3 per share due to its managing general agent (MGA) investments. This bullish outlook is corroborated by Oppenheimer, which initiated with an Outperform rating and a $25 price target, citing the company's strategic overhaul in underwriting and a valuation discount relative to peers. The market appears to be recognizing these improvements, with SPNT shares gaining 14% year-to-date, double the 7% rise of its specialty P&C insurance peers. The company's fundamental outlook is supported by a forecasted 12% return on equity, driven by favorable pricing trends, reserve redundancies, and ongoing expense management, while recent shareholder votes confirm support for the board's governance and strategy.

Key Decisions for Investors

• Given the dual analyst price targets of $25 and $30 suggesting significant upside, investors may consider the current price an attractive entry point to capitalize on the ongoing turnaround story.
• Investors should assess SPNT's price-to-book valuation relative to its peers, as the core of the bull thesis rests on an understated book value and a persistent discount that may narrow as the market recognizes its improved fundamentals.
• It is crucial to monitor the company's execution on its strategic initiatives, particularly its ability to achieve the forecasted 12% return on equity and maintain discipline in underwriting and expense management.